Indeed, we found that Necdin deficiency enhanced the response of leukemia cells expressing MLL-AF9 to chemotherapy treatment, manifested by decreased viability and enhanced apoptosis (Figures 3B and 3E). Here, KMT2A is linked to leukemia.